A Randomized, Controlled, Split-Face, Double-Blind Study Comparing Topical Malassezin to Hydroquinone 4% for Melasma

These findings suggest that malassezin shows comparable efficacy to the gold standard, hydroquinone. Our results further support malassezin as a promising new treatment for patients with melasma. &nbsp.

Authors

E.T. McCraw (ORCID: https://orcid.org/0000-0002-6220-4805)
Nicole Chizara Oparaugo
Tatiana V. Tatarinova (ORCID: https://orcid.org/0000-0003-1787-1112)
Shanaya Dias
P E Grimes

Publication Details

Journal: Journal of Drugs in Dermatology
Published: 2025-12-01
DOI: https://doi.org/10.36849/jdd.9222
Primary Topic: Dermatologic Treatments and Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

A Randomized, Controlled, Split-Face, Double-Blind Study Comparing Topical Malassezin to Hydroquinone 4% for Melasma

E.T. McCraw, Nicole Chizara Oparaugo, Tatiana V. Tatarinova, Shanaya Dias et al.

Dec 1, 2025

Journal of Drugs in Dermatology

Dermatologic Treatments and Research

article

A Randomized, Controlled, Split-Face, Double-Blind Study Comparing Topical Malassezin to Hydroquinone 4% for Melasma

E.T. McCraw, Nicole Chizara Oparaugo, Tatiana V. Tatarinova, Shanaya Dias, P E Grimes

December 1, 2025article en

Abstract

Journal of Drugs in DermatologyVol. 25(1)

Openalex Percentile: Top 23%

Dermatologic Treatments and Research

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Randomized, Controlled, Split-Face, Double-Blind Study Comparing Topical Malassezin to Hydroquinone 4% for Melasma — E.T. McCraw, Nicole Chizara Oparaugo, et al. · Journal of Drugs in Dermatology (2025) | TGRS Research Map | TGRS